Cancer Communications >

2024 , Vol. 44 >Issue 6: 705 - 709

DOI: https://doi.org/10.1002/cac2.12536

Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma

  • Jinkwon Lee 1,2 ,
  • Gyeonghwa Kim 3 ,
  • Tae-Su Han 1,2,4 ,
  • Eunsun Jung 1 ,
  • Taesang Son 1,2 ,
  • Kwangho Kim 1 ,
  • Kiyoon Kwon 1 ,
  • Yuna Roh 1,2 ,
  • Tae Young Ryu 1 ,
  • In Hwan Tae 1 ,
  • Yunsang Kang 1,2 ,
  • Byungheon Lee 3 ,
  • Yu Rim Lee 5 ,
  • Soo Young Park 5 ,
  • Won Young Tak 5 ,
  • Dae-Soo Kim , 1,2 ,
  • Mi-Young Son , 1,2,4 ,
  • Keun Hur , 3,6 ,
  • Hyun-Soo Cho , 1,2,4
Expand
  • 1. Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
  • 2. Department of Bioscience, Korea University of Science and Technology, Daejeon, Republic of Korea
  • 3. Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
  • 4. Department of Biological Science, Sungkyunkwan University, Suwon, Republic of Korea
  • 5. Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • 6. Department of Biomedical Convergence Science and Technology, School of Convergence, Kyungpook National University, Daegu, Republic of Korea
kds2465@kribb.re.kr
myson@kribb.re.kr
KeunHur@knu.ac.kr
chohs@kribb.re.kr

Received date: 02 Sep 2023

Revised date: 24 Feb 2024

Accepted date: 08 Mar 2024

Published date: 20 Jun 2024

Copyright

2024 2024 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.
Fold

Cite this article

Jinkwon Lee , Gyeonghwa Kim , Tae-Su Han , Eunsun Jung , Taesang Son , Kwangho Kim , Kiyoon Kwon , Yuna Roh , Tae Young Ryu , In Hwan Tae , Yunsang Kang , Byungheon Lee , Yu Rim Lee , Soo Young Park , Won Young Tak , Dae-Soo Kim , Mi-Young Son , Keun Hur , Hyun-Soo Cho . Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma[J]. Cancer Communications, 2024 , 44(6) : 705 -709 . DOI: 10.1002/cac2.12536

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

2
Gao X, Wang X, Zhang S. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. Biosci Rep. 2018;38(6):BSR20181441.

3
Chen W, Xiao W, Zhang K, Yin X, Lai J, Liang L, et al. Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence Sci Rep. 2016;6:22976.

4
Liu X, Xu X, Pan B, He B, Chen X, Zeng K, et al. Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer. J Cancer. 2019;10(1):43–50.

5
Wu Y, Wei J, Zhang W, Xie M, Wang X, Xu J. Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma. Onco Targets Ther. 2020;13:7809–18.

6
Wang Q, Wang G, Niu L, Zhao S, Li J, Zhang Z, et al. Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. J Oncol. 2021;2021:6617700.

7
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samadian M. A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion. Front Mol Biosci. 2021;8:763338.

8
Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem. 2022;123(3):506–31.

9
Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, et al. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. BMC Cancer. 2021;21(1):48.

10
Vignali R, Marracci S. HMGA Genes and Proteins in Development and Evolution. Int J Mol Sci. 2020;21(2):654.

Options
Outlines

/

〈 〉